Skip to content
lifestyle.serversfree.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Cantargia
Cantargia Announces Start of New Investigator-Initiated Lung Cancer Prevention Study
June 10, 2026
Cantargia AB to Host Webcast Covering Rights Issue, Loan Agreement, and Strategic Priorities
May 28, 2026
Bulletin from the Annual General Meeting in Cantargia AB (publ)
May 23, 2026
Cantargia Publishes Interim Report for The First Quarter of 2026
May 23, 2026
Invitation to the Presentation of Cantargia’s Interim Report for Q1 2026
May 21, 2026
Cantargia Announces Early Results from Trial of Nadunolimab in MDS and AML
May 17, 2026
Cantargia Announces AACR 2026 Presentation of Study Design and Supportive Pre-Clinical Data for Investigator-Initiated Nadunolimab Study in MSS CRC
May 15, 2026
Cantargia Publishes Annual Report 2025
April 29, 2026
Notice of Annual General Meeting in Cantargia AB (publ)
April 29, 2026
New Preclinical Data on Anti-Tumor Effects of Nadunolimab in Metastatic Colorectal Cancer Presented at the Keystone Cancer Immunotherapy Conference
March 18, 2026
1
2
Next Page
→